Cargando…
Regulation of MYB mediated cisplatin resistance of ovarian cancer cells involves miR-21-wnt signaling axis
c-MYB has been reported to be elevated in few cancers, including in ovarian cancer. It influences resistance to cisplatin but the details are not very well understood. The objective of this study was to further evaluate role of c-MYB in ovarian cancer’s cisplatin resistance. To elucidate the underly...
Autores principales: | Zhang, Xue-yan, Li, Yun-feng, Ma, He, Gao, Yun-he |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181810/ https://www.ncbi.nlm.nih.gov/pubmed/32327705 http://dx.doi.org/10.1038/s41598-020-63396-8 |
Ejemplares similares
-
Hsa_circ_0063804 enhances ovarian cancer cells proliferation and resistance to cisplatin by targeting miR-1276/CLU axis
por: You, Jun, et al.
Publicado: (2022) -
Involvement of the R2R3-MYB transcription factor MYB21 and its homologs in regulating flavonol accumulation in Arabidopsis stamen
por: Zhang, Xueying, et al.
Publicado: (2021) -
HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells
por: Dong, Yu-Jie, et al.
Publicado: (2021) -
LNC00115 Mediates Cisplatin Resistance by Regulating the miR-7/ERK Signalling Pathway in Ovarian Cancer
por: Jiang, Xinyan, et al.
Publicado: (2021) -
MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B
por: Niu, Qin, et al.
Publicado: (2019)